BlackRock Science and Technology Term Trust (NASDAQ:BSTZ – Get Free Report) Portfolio Manager Tony Kim bought 41,825 shares of the business’s stock in a transaction on Thursday, February 5th. The stock was bought at an average cost of $22.00 per share, for a total transaction of $920,150.00. Following the purchase, the portfolio manager directly owned 251,554 shares of the company’s stock, valued at approximately $5,534,188. This trade represents a 19.94% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
BlackRock Science and Technology Term Trust Price Performance
BSTZ traded up $0.53 during midday trading on Monday, reaching $23.09. 135,083 shares of the company were exchanged, compared to its average volume of 306,194. The stock’s 50-day simple moving average is $22.67 and its 200 day simple moving average is $22.19. BlackRock Science and Technology Term Trust has a one year low of $15.22 and a one year high of $23.47.
BlackRock Science and Technology Term Trust Announces Dividend
The firm also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Friday, March 13th will be issued a dividend of $0.1625 per share. The ex-dividend date is Friday, March 13th. This represents a c) annualized dividend and a yield of 8.4%.
Institutional Trading of BlackRock Science and Technology Term Trust
About BlackRock Science and Technology Term Trust
BlackRock Science and Technology Term Trust (NASDAQ: BSTZ) is a closed-end management investment company that provides targeted exposure to companies engaged in the science and technology sectors. Listed on the NASDAQ stock exchange, the trust seeks to deliver total return composed of capital appreciation and monthly distributions over a defined term. It operates as a term trust, with an anticipated liquidation date in August 2028, at which point shareholders will receive proceeds based on the trust’s net asset value.
The trust’s investment strategy is centered on equity and equity-related securities of companies involved in advancing scientific research, technological innovation and related applications.
Featured Articles
- Five stocks we like better than BlackRock Science and Technology Term Trust
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- The day the gold market broke
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for BlackRock Science and Technology Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Science and Technology Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
